Enzo Biochem, Inc. (ENZ) has a market capitalization of $16.44M and trades at $0.31. The 52-week range is 0.252-1.275.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-0.51, annual revenue of $31.91M.
The stock has a beta of 1.16, a last dividend of $0.4000, operates in the Healthcare sector.